Loading…
Loading…
ESMC does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ESMC and 80,000+ other tickers.
See exactly how ESMC's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ESMC and 80,000+ other tickers.
Escalon Medical Corp. specializes in the field of ophthalmology, engaging in the development, manufacturing, promotion, and distribution of both medical devices and pharmaceutical products. Its operations span the United States and international markets. The company's product line includes a variety of diagnostic instruments for eye care. For instance, the A-Scan is designed to provide insights into the internal anatomy of the eye, while the B-Scan assists physicians in diagnosing conditions where the eye's internal media is obscured or cloudy. They also offer the UBM, a high-frequency…
Escalon Medical (OTCMKTS:ESMC - Get Free Report) and Merit Medical Systems (NASDAQ: MMSI - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends. Profitability This table compares Escalon Medical and
Earnings and Valuation This table compares Escalon Medical and Remedent"s revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Escalon Medical $12.05 million 0.10 $110,000.00 ($0.02) -7.75 Remedent $990,000.00 0.01 -$270,000.00 ($0.01) -0.03 Escalon Medical has higher revenue and earnings than Remedent. Escalon Medical is trading at